IsabelleMichelAyoubMDFASN

Nephrology • Columbus, OH

Glomerular Disease, Kidney & Pancreas Transplantation

Assistant Professor of Clinical Medicine

Join to view full profile

Dr. Ayoub is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ayoub's full profile

Already have an account?

Office
543 Taylor Ave
Columbus, OH 43203
Phone+1 614-293-4837

Fax+1 614-293-3125

Education & Training

SUNY Downstate Health Sciences UniversityFellowship, Nephrology, 2011 - 2013
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2008 - 2011
Lebanese University School of MedicineClass of 2005

Certifications & Licensure

OH State Medical License 2014 - 2025
American Board of Internal Medicine Nephrology

Clinical Trials

A Study With Imlifidase in Anti-GBM Disease Start of enrollment: 2022 Dec 22
Recruiting
Phase 3
Roles: Contact
Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome Start of enrollment: 2023 Jan 01
Withdrawn
Phase 2
Roles: Contact

Publications & Presentations

PubMed

Semaglutide and kidney function: direct kidney protection or an artifact?
Isabelle Ayoub, Germaine Wong, Richard J Glassock
Kidney International. 2024-11-19
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.
Brad H Rovin, Pierre M Ronco, Jack F M Wetzels, Sharon G Adler, Isabelle Ayoub
Kidney International Reports. 2024-09-01
2 citations
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes.
Daniel Edmonston, Elizabeth Lydon, Hillary Mulder, Karen Chiswell, Zachary Lampron
JAMA Network Open. 2024-06-03

Press Mentions

New Findings Add to Questions About Existence of Gouty NephropathyJanuary 13th, 2021
Clinical Trials, Non-Drug Studies at the Ohio State University Wexner Medical Center Aim to Slow Kidney Disease ProgressionJanuary 24th, 2021
New KDOQI Commentary of 2021 KDIGO Clinical Practice Guideline for Glomerular Diseases PublishedJune 23rd, 2023